Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ferrara

Showing results (291-300 of 301) with videos related to

Pageof 31
Sort By:
Leukemia|May 24, 2003
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocolsF Mandelli, R Latagliata, G Avvisati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2011
Primary plasma cell leukemia: a retrospective multicenter study of 73 patientsL Pagano, C G Valentini, V De Stefano, et al.
Annals of Hematology|June 26, 2020
KRD (carfilzomib and lenalidomide plus dexamethasone) for the treatment of relapsed or refractory multiple myeloma in the real-life: a retrospective survey in 123 patientsSalvatore Palmieri, S Rocco, O Vitagliano, et al.
European Journal of Internal Medicine|November 18, 2023
Phenotyping pleural effusion in patients hospitalized in Internal Medicine wards with decompensated heart failureArianna Bartoli, Mattia Donadoni, Elisa Ceriani, et al.
Leukemia|November 28, 2006
HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemiaA-L Herr, M Labopin, D Blaise, et al.
Blood|August 15, 2000
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groupsM A Sanz, F Lo Coco, G Martín, et al.
Bone Marrow Transplantation|November 17, 2015
Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMTL Sellner, A Boumendil, H Finel, et al.
Leukemia|June 8, 2026
Normal life expectancy after all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemiaA Piciocchi, A Talone, M Messina, et al.
The Pharmacogenomics Journal|December 6, 2017
Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primatesD I Staquicini, S D'Angelo, F Ferrara, et al.
Leukemia|May 3, 2016
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapyL Cicconi, M Divona, C Ciardi, et al.
Pageof 31

Showing results (291-300 of 301) with videos related to

Sort By:
Pageof 31
Leukemia|May 24, 2003
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocolsF Mandelli, R Latagliata, G Avvisati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2011
Primary plasma cell leukemia: a retrospective multicenter study of 73 patientsL Pagano, C G Valentini, V De Stefano, et al.
Annals of Hematology|June 26, 2020
KRD (carfilzomib and lenalidomide plus dexamethasone) for the treatment of relapsed or refractory multiple myeloma in the real-life: a retrospective survey in 123 patientsSalvatore Palmieri, S Rocco, O Vitagliano, et al.
European Journal of Internal Medicine|November 18, 2023
Phenotyping pleural effusion in patients hospitalized in Internal Medicine wards with decompensated heart failureArianna Bartoli, Mattia Donadoni, Elisa Ceriani, et al.
Leukemia|November 28, 2006
HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemiaA-L Herr, M Labopin, D Blaise, et al.
Blood|August 15, 2000
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groupsM A Sanz, F Lo Coco, G Martín, et al.
Bone Marrow Transplantation|November 17, 2015
Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMTL Sellner, A Boumendil, H Finel, et al.
Leukemia|June 8, 2026
Normal life expectancy after all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemiaA Piciocchi, A Talone, M Messina, et al.
The Pharmacogenomics Journal|December 6, 2017
Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primatesD I Staquicini, S D'Angelo, F Ferrara, et al.
Leukemia|May 3, 2016
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapyL Cicconi, M Divona, C Ciardi, et al.
Pageof 31